Thor Medical ASA Awards CTO Prof. Hassfjell Shares Under Incentive Program

(AWP Alliance News) - Thor Medical ASA has awarded Chief Technology Officer Prof. Sindre Hassfjell a cash bonus, with the net amount after taxes to be invested in new shares of the company. This bonus recognizes Prof. Hassfjell's significant contributions to Thor Medical's intellectual property portfolio. As part of the arrangement, 63,739 new shares have been issued to Prof. Hassfjell at a subscription price of NOK 4.95 per share, reflecting the volume-weighted average tradi…

Thor Medical - Issuance of shares to executive member under incentive program

6.1.2026 08:52:15 CET | Thor Medical ASA | Mandatory notification of tradeprimary insiders6 January 2026 | Thor Medical ASA | Mandatory notification of trade primaryinsidersThe Board of Directors of Thor Medical ASA (the "Company") has decided to awardChief Technology Officer Prof. Sindre Hassfjell a cash bonus, subject to the netbonus after taxes being invested in shares in the Company.The award is made in recognition of Prof. Hassfjell's significant contributions,to date an…

Thor Medical Starts Equipment Installation Work at AlphaOne Isotope Plant in Norway

04:36 AM EST, 12/23/2025 (MT Newswires) -- Thor Medical (TRMED.OL) said Tuesday that it has started installing equipment at its AlphaOne plant, its first under-construction commercial-scale isotope production facility at Herøya Industrial Park, Norway. The Norwegian producer of alpha-emitters for cancer therapy noted that it has taken over the laboratory and infrastructure at the Herøya Park and installed the first storage tanks for thorium raw material. Meanwhile, building a…

TRMED: Thor Medical reaches key construction milestones at AlphaOne plant

23.12.2025 08:00:00 CET | Thor Medical ASA | Non-regulatory press releasesOslo, 23 December 2025 - Thor Medical, a leading emerging supplier ofalpha-emitters for next-generation precision cancer treatment, has now startedequipment installation at the AlphaOne plant, its first commercial-scale isotopeproduction facility under construction at Herøya Industrial Park, Norway.Thor Medical has officially taken over the new laboratory and associatedinfrastructure at Herøya and compl…

TRMED: RadioMedix and Thor Medical enter supply agreement for thorium-228

4.12.2025 08:00:01 CET | Thor Medical ASA | Non-regulatory press releasesOSLO and HOUSTON, December 4, 2025 - Thor Medical ASA, a leading emergingsupplier of alpha-emitters for next-generation precision cancer treatment, andRadioMedix, Inc., a U.S. based clinical-stage biotechnology company focused oninnovative targeted radiopharmaceuticals for diagnosis, monitoring and cancertherapy, have entered into a five-year frame agreement for the supply ofthorium-228 (Th-228). The sup…

BioStock: Thor Medical advances toward commercial scale following pilot success and major deal streak

With its pilot facility now fully operational, Thor Medical has secured a string of strategic supply agreements that propel the company toward full-scale commercial production. This commercial momentum has led to to the investment in AlphaOne, the company's first industrial-scale facility, positioning Thor Medical as a key supplier of alpha-emitters for next-generation precision cancer treatments. BioStock contacted CEO Jasper Kurth to learn more. biostock.se https://bios…

Thor Medical · 2024 financial report

Thor Medical · 2024-H1 financial report